Texas Tech University
Also known as: Department of Anesthesiology; Texas Tech University Health Sciences Center; Paul L. Foster School of Medicine | Texas Tech Health Science Center | Texas Tech Health Sciences Center | Texas Tech Health Sciences Center Department of Internal Medicine | Texas Tech Health Sciences Center El Paso | Texas Tech UHSC | Texas Tech University | Texas Tech University- Department of Nutritional Sciences | Texas Tech University Health and Sciences Center | Texas Tech University Health Sciences Center | Texas Tech University Health Sciences Center, Department of Emergency Medicine | Texas Tech University Health Sciences Center Department of Orthopaedic Surgery | Texas Tech University Health Sciences Center El Paso | Texas Tech University Health Sciences Center, El Paso | Texas Tech University Health Sciences Center- El Paso, Texas | Texas Tech University Health Sciences Center- Paul L. Foster School of Medicine of El Paso | Texas Tech University Health Sciences Center School of Pharmacy | Texas Tech University HSC | TTUHSC | TTUHSC department of Surgery | TTUHSC dept. Orthopaedic Surgery
Highest phase reached
Phase 4
First clinical trial
Sep 1, 2000Last known activity
Oct 15, 2025
Timeline
1920s
- Feb 10, 1923
Texas Tech University— Founded
Drugs by trial phase (93 distinct, 89 trials)
Phase 4 (20 own, 0 via acquisition)
Phase 3 (11 own, 0 via acquisition)
Phase 2 (18 own, 0 via acquisition)
Phase 1 (18 own, 0 via acquisition)
Other trials (26 own, 0 via acquisition)
Indications
Studied for
- Anemia, Iron-Deficiency
- Arsenic Poisoning
- Arthralgia
- Attention Deficit Disorder with Hyperactivity
- Back Pain
- Breast Neoplasms
- Burns
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Cardiotoxicity
- Constipation
- Coronary Artery Disease
- Cough
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Emergencies
- Fibrosis
- Hyperkinesis
- Hypersensitivity
- Hypogonadism
- Idiopathic Pulmonary Fibrosis
- Infarction
- Insulin Resistance
- Keratosis
- Keratosis, Actinic
- Leprosy
- Leukemia
- Leukemia, Lymphoid
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Low Back Pain
- Lung Diseases
- Lung Diseases, Interstitial
- Lung Diseases, Obstructive
- Lymphoma
- Lymphoma, Non-Hodgkin
- Melanosis
- Multiple Sclerosis
- Mycoses
- Myocardial Infarction
- Neuroblastoma
- Nutrition Disorders
- Obesity
- Obesity, Morbid
- Osteoporosis
- Ovarian Neoplasms
- Poisoning
- Postoperative Pain
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Pulmonary Disease, Chronic Obstructive
- Pulmonary Fibrosis
- Respiratory Insufficiency
- Respiratory Tract Diseases
- Sclerosis
- Sepsis
- Tuberculosis
- Urinary Bladder, Neurogenic
- Vitamin D Deficiency
- Vomiting
Recent trials (50)
- NCT06903819Lead sponsorPhase 4Oct 15, 2025
- NCT06817018Lead sponsorPhase 2Mar 1, 2025
- NCT06817018Sponsor investigatorPhase 2Mar 1, 2025
- NCT06585865Sponsor investigatorN/AFeb 28, 2025
- NCT06585865OfficialN/AFeb 28, 2025
- NCT06585865Lead sponsorN/AFeb 28, 2025
- NCT06639282CollaboratorPhase 2Nov 30, 2024
- NCT06639282OfficialPhase 2Nov 30, 2024
- NCT05999825CollaboratorPhase 2Sep 30, 2024
- NCT06303128CollaboratorPhase 3Feb 3, 2024
- NCT06303128Sponsor investigatorPhase 3Feb 3, 2024
- NCT06303128Lead sponsorPhase 3Feb 3, 2024
- NCT06303128OfficialPhase 3Feb 3, 2024
- NCT06177028CollaboratorPhase 2Jan 2, 2024
- NCT06091189Lead sponsorEarly Phase 1Nov 30, 2023
Details
- Founded
- Lubbock, TX, US Feb 10, 1923
- Last known activity
- Oct 15, 2025